Skip to main content
. 2016 Feb 26;7(14):18876–18886. doi: 10.18632/oncotarget.7739

Figure 4. Genomic alteration in the entire cohort of adenocarcinoma samples.

Figure 4

A. EGFR alteration. 23% of the EGFR tested samples showed genetic alteration. EGFR exon 19 deletion and gene amplification showed in majority of the samples. B. KRAS alteration. 25% of KRAS tested samples showed genetic alteration and 40% of these KRAS alteration samples had G12C mutation. C. ALK alteration. 9% of ALK tested samples showed genetic alteration and 83% of these ALK alteration samples had EML4-ALK rearrangements.